Verigene Enteric Pathogens Nucleic Acid Test (EP) for detecting and identification of pathogenic...

FDA Device Recall #Z-2952-2018 — Class II — May 8, 2018

Recall Summary

Recall Number Z-2952-2018
Classification Class II — Moderate risk
Date Initiated May 8, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Luminex Corporation
Location Austin, TX
Product Type Devices
Quantity 790 Cartridge Carriers containing 3160 Cartridges

Product Description

Verigene Enteric Pathogens Nucleic Acid Test (EP) for detecting and identification of pathogenic enteric bacteria, viruses, and genetic virulence markers from liquid or soft stool preserved in Cary-Blair medium, collected from individuals with signs and symptoms of gastrointestinal infection.

Reason for Recall

Elevated false positive results Yersinia enterocolitica (Yersinia) from customers using the EP Nucleic Acid Test Cartridges component (20-006-023) from the Verigene EP Nucleic Acid Test Kit (20-005-023).

Distribution Pattern

Domestic Distribution: Arizona, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Kansas, Michigan, Minnesota, Missouri, New Hampshire, Tennessee, Texas, Utah, West Virginia, Wisconsin.

Lot / Code Information

Catalog number 20-005-023; Cartridge Catalog number 20-006-023; Lot 032718023A; UDI 00857573006041

Other Recalls from Luminex Corporation

Recall # Classification Product Date
Z-1903-2025 Class II VERIGENE Gram Negative Blood Culture (BC-GN) Nu... Apr 16, 2025
Z-2533-2024 Class II Verigene Gram Positive Blood Culture (BC-GP) Nu... Jun 20, 2024
Z-0500-2024 Class II Luminex VERIGENE BC-GP Utility Tray (5-Pack Car... Nov 7, 2023
Z-2023-2023 Class II Verigene Enteric Pathogens Nucleic Acid Test (E... Jun 5, 2023
Z-2024-2023 Class II VERIGENE Clostridium difficile Nucleic Acid Tes... Jun 5, 2023

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.